The ends justify the means ? With such remarkable promise they can't locate something other than a lender of last resort .Headwinds created by financing are what has kept us rangebound for some time.Look at TP's track record.When they are out of the mix, and we achieve clinical endpoints, critical mass will propel us to blue sky. IMO
Market Data 
Markets 
AI
